von Willebrand factor, tissue plasminogen activator, and dehydroepiandrosterone sulphate predict cardiovascular death in a 10 year follow up of survivors of acute myocardial infarction

被引:89
作者
Jansson, JH
Nilsson, TK
Johnson, O
机构
[1] Umea Univ Hosp, Dept Clin Chem, S-90185 Umea, Sweden
[2] Umea Univ Hosp, Dept Internal Med, S-90185 Umea, Sweden
[3] Skelleftea Hosp, Dept Internal Med, Skelleftea, Sweden
关键词
myocardial infarction; risk factors; fibrinolysis; tissue plasminogen activator; plasminogen activator inhibitor; von Willebrand factor; dehydroepiandrosterone sulphate;
D O I
10.1136/hrt.80.4.334
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background-Haemostasis plays a major part in the process initiating a myocardial infarction. The impact of haemostatic variables on long term prognosis is unknown. Objective-To evaluate van Willebrand factor (vWF), tissue plasminogen activator antigen (t-PA) and its activity before and after venous occlusion, plasminogen activator inhibitor (PAH-P), dehydroepiandrosterone sulphate (DHEAS), and established clinical risk factors as long term predictors for reinfarction and mortality. Patients-123 consecutive survivors of myocardial infarction followed up for 10 years. Design-Study entry took place between 1982 and 1983. Fifty seven patients died (54 of cardiovascular disease) during the mean observation time of PO years. Results-Cox's univariate regression analysis showed that cardiovascular mortality was significantly associated with age, hypertension, previous history of angina pectoris, DHEAS, mass concentration of t-PA, and vWF. These associations were significant for vWF and mass concentration of t-PA after adjusting for age and hypertension. Conclusions-A low concentration of DHEAS and, high levels of the endothelially derived haemostatic variables vWF and mass concentration of P-PA are predictors of cardiovascular mortality in survivors of myocardial infarction. This association is independent of established clinical risk factors for mass concentration of t-PA and vWF.
引用
收藏
页码:334 / 337
页数:4
相关论文
共 29 条
[1]   A PROSPECTIVE-STUDY OF DEHYDROEPIANDROSTERONE SULFATE, MORTALITY, AND CARDIOVASCULAR-DISEASE [J].
BARRETTCONNOR, E ;
KHAW, KT ;
YEN, SSC .
NEW ENGLAND JOURNAL OF MEDICINE, 1986, 315 (24) :1519-1524
[2]  
BENDAVID M, 1967, P SOC EXP BIOL MED, V125, P1136
[3]  
BLOTH B, 1976, ACTA MED SCAND, V200, P281
[4]  
BOWIE EJW, 1993, THROMBOSIS AND ITS MANAGEMENT, P134
[5]  
BRANNSTROM M, 1995, THROMB HAEMOSTASIS, V74, P612
[6]   THERAPEUTIC EFFECTS OF DEHYDROEPIANDROSTERONE (DHEA) IN DIABETIC MICE [J].
COLEMAN, DL ;
LEITER, EH ;
SCHWIZER, RW .
DIABETES, 1982, 31 (09) :830-833
[7]  
CONTOREGGI CS, 1990, J ANDROL, V11, P460
[8]   THE PLAT STUDY - HEMOSTATIC FUNCTION IN RELATION TO ATHEROTHROMBOTIC ISCHEMIC EVENTS IN VASCULAR-DISEASE PATIENTS PRINCIPAL RESULTS [J].
CORTELLARO, M ;
BOSCHETTI, C ;
COFRANCESCO, E ;
ZANUSSI, C ;
CATALANO, M ;
DEGAETANO, G ;
GABRIELLI, L ;
LOMBARDI, B ;
SPECCHIA, G ;
TAVAZZI, L ;
TREMOLI, E ;
DELLAVOLPE, A ;
POLLI, E ;
AGRIFOGLIO, G ;
BUGIANI, O ;
COBELLI, F ;
DONATI, MB ;
GARATTINI, S ;
LIBRETTI, A ;
MANTEGAZZA, P ;
MONTEMARTINI, C ;
PAOLETTI, R .
ARTERIOSCLEROSIS AND THROMBOSIS, 1992, 12 (09) :1063-1070
[9]  
COX DR, 1972, J R STAT SOC B, V34, P187
[10]   PLATELET VONWILLEBRAND-FACTOR [J].
GRALNICK, HR ;
WILLIAMS, SB ;
MCKEOWN, LP ;
MAGRUDER, L ;
HANSMANN, K ;
VAIL, M ;
PARKER, RI .
MAYO CLINIC PROCEEDINGS, 1991, 66 (06) :634-640